- ￥650 - 6250
- MedChemExpress(MCE)
- 美国
- HY-14622
- 2025年07月16日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
852391-19-6
- 规格：
10 mM * 1 mL/1 mg/5 mg/10 mg/50 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥1986.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥650.0 |
| 规格： | 5 mg | 产品价格： | ￥1730.0 |
| 规格： | 10 mg | 产品价格： | ￥2623.0 |
| 规格： | 50 mg | 产品价格： | ￥6250.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Necrostatin 2
CAS No. : 852391-19-6
MCE 国际站：Necrostatin 2
产品活性：Necrostatin 2 是一种有效的程序性坏死 (necroptosis) 抑制剂。作用于TNF-α处理的FADD缺陷型Jurkat T细胞，抑制程序性坏死，EC50 为 0.05 μM。Necrostatin 2 为 RIPK1 抑制剂。
研究领域：Apoptosis
作用靶点：RIP kinase
In Vitro: Evaluation of necroptosis inhibitory activity is performed using a FADD-deficient variant of human Jurkat T cells treated with TNF-α. Utilizing these conditions the cells efficiently undergo necroptosis, which is completely and selectively inhibited by Necrostatin 2 (EC50=50 nM). Necrostatin 2 shows activity in a broad range of necroptosis cellular systems. Necrostatin 2 at 30 μM completely protects L929 cells from TNF-α-induced necroptosis. In addition to TNF-α, the pan-caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD.fmk) has also been found to induce necrosis in L929 cells, which is efficiently inhibited by Necrostatin 2. EC50 for inhibition of necroptosis in FADD-deficient Jurkat T cells treated with TNF-α is 0.05 μM.
相关产品：Bioactive Compound Library Plus | Apoptosis Compound Library | Kinase Inhibitor Library | NF-κB Signaling Compound Library | Anti-Cancer Compound Library | Cancer Stem Cells Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Serine/Threonine Kinase Inhibitor Library | Necrostatin-1 | GSK-872 | Necrostatin 2 racemate | GSK2982772 | GSK583 | GSK-843 | GSK840 | GSK547 | RIPA-56 | RIP1/RIP3/MLKL activator 1 | WEHI-345 | GSK2983559 | PROTAC RIPK degrader-2 | Apostatin-1 | GSK3145095 | HS-1371 | GSK2593074A | GSK963 | PROTAC RIPK degrader-6 | RIPK3-IN-1 | Eclitasertib | ICCB-19 hydrochloride | OD36 | GSK481 | PK68 | RIP1 kinase inhibitor 1 | RIPK-IN-4
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Methods to Analyze Cellular Necroptosis
, and the methods to analyze the inhibitory effects of anti-necroptosis compounds (necrostatin-1).
Nature 背靠背 | 浙大周青/John Silke 团队揭示关键蛋白激酶调控自体免疫疾病的分子机制
了外源的一系列刺激，用于引发细胞死亡与炎症反应。结果表明，相比健康供体来源的 PBMC，患者的细胞死亡程度与炎症反应程度明显加强。此外，通过对野生型以及突变体的小鼠来源的 MEF 进行体外检测也证明了这一点。由下图可以看出，相比健康供体（蓝色），患者来源的细胞响应 TNFa（T）以及 SM-164（S）后细胞死亡程度更加明显，这一效应不能被细胞凋亡抑制剂 z-VAD-FMK（Z）抑制，但能够被细胞坏死性凋亡抑制剂 Necrostatin（N）抑制，表明引发的是坏死性凋亡。图片来源：Nature另一
相关专题 his method was successful in our lab using prostate tissue and for our specific objectives. Investigators must be aware that they will need to tailor the following protocol for their own research objectives
技术资料暂无技术资料 索取技术资料
